Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Liabilities from Discontinued Operations (2022 - 2023)

Updated

Pasithea Therapeutics (KTTA) reported Liabilities from Discontinued Operations of $299,669 for Q1 2023, down 6.2% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

At the end of FY2022, Pasithea Therapeutics posted Liabilities from Discontinued Operations of $319,575.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pasithea Therapeutics 16.04 Mn 16.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 299,669.00
Dec 31, 2022 319,575.00
API Access

Pasithea Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=KTTA&period=max&api_key=YOUR_API_KEY